Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. Five out of 10 post-mortem brains of patients ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

A study links living near golf courses to higher Parkinson's risk, with strongest association found in those one to three ...